Why making smoking cessation a priority for rare interstitial lung disease smokers?
- PMID: 39015486
- PMCID: PMC11249982
- DOI: 10.18332/tpc/190591
Why making smoking cessation a priority for rare interstitial lung disease smokers?
Abstract
This review aims to discuss the complex relationship between smoking and interstitial lung diseases (ILDs), emphasizing the significant morbidity and mortality associated with these conditions. While the etiology of ILDs remains multifactorial, cigarette smoking emerges as a prominent modifiable risk factor implicated in their pathogenesis and progression. This narrative review will provide insight into smoking-associated interstitial lung diseases and personalised approaches to smoking cessation. Epidemiological studies consistently link smoking to ILDs such as idiopathic pulmonary fibrosis (IPF), respiratory bronchiolitis-associated ILD (RB-ILD), and desquamative interstitial pneumonia (DIP), highlighting the urgent need for comprehensive tobacco cessation strategies. Despite the established benefits of smoking cessation, adherence to cessation programs remains challenging due to nicotine addiction, psychological factors, and social influences. The modest success rates of smoking cessation in ILD patients, emphasises the importance of tailored interventions and ongoing support is needed to overcome barriers and to improve outcomes of quitting smoking in this category of vulnerable patients.
Keywords: Interstitial lung disease; smoking-associated diseases; tobacco cessation.
© 2024 Vicol C. et al.
Conflict of interest statement
The authors have completed and submitted the ICMJE Form for disclosure of Potential Conflicts of Interest and none was reported.
Figures
References
-
- American Thoracic Society; European Respiratory Society . American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 [published correction appears in Am J Respir Crit Care Med2002 Aug 1;166(3):426]. Am J Respir Crit Care Med. 2002;165(2):277-304. doi:10.1164/ajrccm.165.2.ats01 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources